NCT01597310View on ClinicalTrials.gov

Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Healthy Volunteers

Interventions

DRUG

Warfarin

single doses at specified time periods

DRUG

Dexpramipexole

multiple doses

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

Knopp Biosciences

All Listed Sponsors

lead

Knopp Biosciences

INDUSTRY

NCT01597310 - Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study | Biotech Hunter | Biotech Hunter